Clinical Trials Search at Vanderbilt-Ingram Cancer Center

An International, Prospective, Open-label, Multi-Center, Randomized Phase III Study comparing Lutetium (177Lu) Vipivotide Tetraxetan (AAA617) versus Observation to Delay Castration or Disease Recurrence in Adult Male Patients with Prostate-Specific Membrane Antigen (PSMA) Positive Oligometastatic Prostate Cancer (OMPC)

Disease Sites:

Not Available

Staging:

Phase III

Age Group:

Adults

Therapies:

Not Available

Drugs:

Not Available

Principal Investigator(s):

Schaffer, Kerry

Scope:

International

Participating Institutions:

Vanderbilt University

Open Date:

01-21-2025

Trial Type:

Treatment

Protocol ID:

VICC-DTURO23342

National Clinical Trial ID:

NCT05939414

Related Internal Documents:

View Internal Documents

Eligibility

Ages Eligible for Study:

Not Available

Genders Eligible for Study:

Not Available

Accepts Healthy Volunteers?:

Not Available